• 1
    Neild GH, Rodriguez-Justo M, Wall C, Connolly JO. Hyper-IgG4 disease: Report and characterization of a new disease. BMC Med. 2006; 4: 23.
  • 2
    Masaki Y, Kurose N, Umehara H. IgG4-related disease: A novel lymphoproliferative disorder discovered and established in Japan in the 21st century. J. Clin. Exp. Hematop. 2011; 51: 1320.
  • 3
    Umehara H, Okazaki K, Masaki Y et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD). Mod. Rheumatol. 2012; 22: 2130.
  • 4
    Church NI, Pereira SP, Deheragoda MG et al. Autoimmune pancreatitis: Clinical and radiological features and objective response to steroid therapy in a UK series. Am. J. Gastroenterol. 2007; 102: 24172425.
    Direct Link:
  • 5
    Comings DE, Skubi KB, Van Eyes J, Motulsky AG. Familial multifocal fibrosclerosis. Findings suggesting that retroperitoneal fibrosis, mediastinal fibrosis, sclerosing cholangitis, Riedel's thyroiditis, and pseudotumor of the orbit may be different manifestations of single disease. Ann. Intern. Med. 1967; 66: 884892.
  • 6
    Fukuda W, Kimura M, Akaogi T et al. Multifocal fibrosclerosis: Retroperitoneal fibrosis associated with a suprasellar tumor and pachymeningitis. Intern. Med. 2003; 42: 10061010.
  • 7
    Tada M, Onodera O, Hara K et al. Oral cyclophosphamide therapy for multifocal fibrosclerosis with hypertrophic intracranial pachymenigitis. Clin. Neurol. 2006; 46: 128133 (in Japanese).
  • 8
    Kamisawa T, Okamoto A. Autoimmune pancreatitis: Proposal of IgG4-related sclerosing disease. J. Gatroenterol. 2006; 41: 613625.